Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Covestro reports renewable electricity fully powers four US sites

February 19, 2025 By MDO Staff

NEWS RELEASE: Four Covestro U.S. Sites Now Running Entirely on Renewable Electricity

  • Result of virtual Power Purchase Agreement (vPPA) with Ørsted
  • Provides 90 MW of renewable energy capacity
  • Reduces approximately 90,000 tons of CO2 emissions annually

[Photo courtesy of Covestro]

PITTSBURGH — Covestro, a world-leading supplier of high-tech polymer materials, today announced that four of its U.S. sites have reached net-zero Scope 2 electricity emissions through the allocation of Renewable Energy Certificates (RECs). This achievement is a result of Covestro’s existing virtual Power Purchase Agreement (vPPA) with Ørsted, a clean energy leader in the U.S. market, headquartered in Denmark.

The Covestro U.S. sites Channelview, Texas, South Deerfield, Massachusetts, New Martinsville, West Virginia and Pittsburgh, Pennsylvania, have achieved net-zero Scope 2 emissions for electricity. Going one step further, the sites in South Deerfield, New Martinsville, and Pittsburgh have now achieved complete net-zero Scope 2 emissions. The remaining credits have been applied to Covestro’s Baytown, Texas facility.

“Even in a persistently challenging market environment, we are working towards our goal of climate-neutral production by 2035 and are consistently implementing our strategy of fully aligning ourselves with the circular economy,” said Thorsten Dreier, CTO of Covestro. “By leveraging renewable energy, we’re not just reducing our carbon footprint – we’re actively shaping a brighter future for our industry.”

The agreement with Ørsted, which provides Covestro with 90 MW of renewable energy capacity, will reduce approximately 90,000 tons of CO2 emissions annually. This represents a significant step towards Covestro’s goal of climate neutral production by 2035.

“Our partnership with Ørsted is a prime example of how collaboration and innovation can drive meaningful change in our industry,” says Samir Hifri, chairman and president of Covestro LLC. “We’re proud to be at the forefront of sustainable practices in the chemical sector and look forward to continuing to execute our strategy to grow sustainably in the U.S.”

This announcement follows Covestro’s recent low triple digit million Euro investments across multiple U.S. sites, further solidifying the company’s commitment to growth and sustainability in the North American market.

About Covestro

Covestro is one of the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from Covestro are also used in sectors such as sports and leisure, telecommunications and health, as well as in the chemical industry itself.

The company is geared completely to the circular economy. In addition, Covestro aims to achieve climate neutrality for its Scope 1 and Scope 2 emissions by 2035, and the Group’s Scope 3 emissions are also set to be climate neutral by 2050. Covestro generated sales of EUR 14.4 billion in fiscal year 2023. At the end of 2023, the company had 48 production sites worldwide and employed approximately 17,500 people (calculated as full-time equivalents).

Find more information at www.covestro.us

The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.

Related Articles Read More >

A close of of Medical 21's Maverics graft.
A surgeon’s prayer helped St. Jude Medical founder Manny Villafaña size his latest device
The 1.84 volt paper battery (brown circle structure) was tested in pigs with a bioabsorbable radio-frequency identification (RFID) device.
MIT researchers develop bioresorbable batteries for ingestible medical devices
PE firm Vance Street merges medtech suppliers MRPC, PDC and Injectech
A photo of disposable syringes for insulin.
How to make smarter polymer choices for disposable drug delivery devices
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2025 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe